Tevogen Bio Holdings Inc. (TVGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 54.98M |
| Enterprise Value | 57.53M |
| P/E Ratio | -1.91 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -4.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.34 |
| Return On Equity | 2.41 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -25.57M |
| Net Income | -26.28M |
| Diluted EPS | -8.08 |
| Total Cash | 692,305 |
| Total Cash/Share | 0.2 |
| Total Debt | 3.07M |
| Total Debt/Equity | -0.31 |
| Current Ratio | 0.29 |
| Book Value Per Share | -2.82 |
| 52-Week Change | -81.62 |
| 52-Week High | 71 |
| 52-Week Low | 4.14 |
| Moving Average 50 Days | 7.77 |
| Moving Average 200 Days | 19.31 |
| Average Volume | 33,866 |
| Shares Outstanding | 4.19M |
| % Held by Institutions | 4.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | March 06, 2026 |